THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 10-K: Annual report
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 8-K: The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-10% Owner Havencrest Healthcare Partners, L.P.
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-10% Owner Havencrest Healthcare Partners, L.P.
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-10% Owner Havencrest Healthcare Partners, L.P.
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 144: Notice of proposed sale of securities pursuant to Rule 144
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Havencrest Healthcare Partners GP, LLC(12.04%),Havencrest Healthcare Partners, L.P.(11.93%), etc.
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-10% Owner Havencrest Healthcare Partners, L.P.
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Director BARASCH RICHARD A
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Director Hively Brad
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Director Johnson Karen Marie
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Director Kaushal Mohit
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Director Ling Gabriel
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Director McGeorge Anne
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Director O'Meara Maeve
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Director Pacala Mark L
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Shah Mihir
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Chief Operating Officer Castle Jeremy
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Director Hively Brad
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Virnich Daniel
No Data